Literature DB >> 8341295

Lewy bodies in the lateral hypothalamus: do they imply neuronal loss?

H P Kremer1, G T Bots.   

Abstract

Lewy bodies have been found in the hypothalamic lateral tuberal nucleus (NTL) and the adjoining tuberomammillary nucleus (TM) in Parkinson's disease (PD). The NTL is severely atrophic in Huntington's disease; the TM seems unaffected. In this study, we examined the NTL and the TM of seven PD patients and one patient with presumed PD to assess whether the presence of Lewy bodies indicated neuronal loss. Most Lewy bodies were found in the TM, but they were also present in the NTL of seven of the eight patients. The number of NTL neurons in the PD patients was similar to a group of 14 nonneurological controls, seven Alzheimer's disease (AD) patients, and two AIDS patients with dementia. This challenges the hypothesis that Lewy bodies are a sign of significant cell death. The TM, whose cells could not be counted, did not seem depleted in neuronal numbers, although occasional neuronophagia was observed.

Entities:  

Mesh:

Year:  1993        PMID: 8341295     DOI: 10.1002/mds.870080310

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  9 in total

Review 1.  Selective neuronal vulnerability in Parkinson disease.

Authors:  D James Surmeier; José A Obeso; Glenda M Halliday
Journal:  Nat Rev Neurosci       Date:  2017-01-20       Impact factor: 34.870

2.  Novel Neuroprotective Effects of Melanin-Concentrating Hormone in Parkinson's Disease.

Authors:  Ji-Yeun Park; Seung-Nam Kim; Junsang Yoo; Jaehwan Jang; Ahreum Lee; Ju-Young Oh; Hongwon Kim; Seung Tack Oh; Seong-Uk Park; Jongpil Kim; Hi-Joon Park; Songhee Jeon
Journal:  Mol Neurobiol       Date:  2016-11-14       Impact factor: 5.590

3.  Differential α-synuclein expression contributes to selective vulnerability of hippocampal neuron subpopulations to fibril-induced toxicity.

Authors:  Esteban Luna; Samantha C Decker; Dawn M Riddle; Anna Caputo; Bin Zhang; Tracy Cole; Carrie Caswell; Sharon X Xie; Virginia M Y Lee; Kelvin C Luk
Journal:  Acta Neuropathol       Date:  2018-03-03       Impact factor: 17.088

Review 4.  Sleep disturbances in Alzheimer's and Parkinson's diseases.

Authors:  Sarah M Rothman; Mark P Mattson
Journal:  Neuromolecular Med       Date:  2012-05-03       Impact factor: 3.843

5.  Sleep alterations in an environmental neurotoxin-induced model of parkinsonism.

Authors:  Kimberly A McDowell; Maria M Hadjimarkou; Shaun Viechweg; Avigail E Rose; Sarah M Clark; Paul J Yarowsky; Jessica A Mong
Journal:  Exp Neurol       Date:  2010-08-14       Impact factor: 5.330

Review 6.  Parkinson's Disease Is Not Simply a Prion Disorder.

Authors:  D James Surmeier; José A Obeso; Glenda M Halliday
Journal:  J Neurosci       Date:  2017-10-11       Impact factor: 6.167

Review 7.  On Cell Loss and Selective Vulnerability of Neuronal Populations in Parkinson's Disease.

Authors:  Nicolas Giguère; Samuel Burke Nanni; Louis-Eric Trudeau
Journal:  Front Neurol       Date:  2018-06-19       Impact factor: 4.003

8.  Inhibition of Orexin/Hypocretin Neurons Ameliorates Elevated Physical Activity and Energy Expenditure in the A53T Mouse Model of Parkinson's Disease.

Authors:  Milos Stanojlovic; Jean Pierre Pallais; Catherine M Kotz
Journal:  Int J Mol Sci       Date:  2021-01-14       Impact factor: 5.923

9.  Hypocretin (orexin) cell loss in Parkinson's disease.

Authors:  Thomas C Thannickal; Yuan-Yang Lai; Jerome M Siegel
Journal:  Brain       Date:  2007-05-09       Impact factor: 13.501

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.